日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Phase I study on neoadjuvant combination immunotherapy with mogamulizumab and nivolumab for solid tumors

针对实体瘤的新辅助联合免疫疗法(mogamulizumab 和 nivolumab)的 I 期研究

Koichi Jinushi #,Takuro Saito #,Koji Kurose,Susumu Suzuki,Takashi Kojima,Taishi Takahara,Tomoki Makino,Tetsuya Ogawa,Hiroyoshi Nishikawa,Kazuhiro Kakimi,Shinsuke Iida,Jun Nakajima,Yuichiro Doki,Mikio Oka,Ryuzo Ueda,Hisashi Wada

Arrhythmias in Cronkhite-Canada Syndrome

克朗凯特-加拿大综合征的心律失常

Deguchi, Ryuzo; Ueda, Takashi; Sano, Masaya; Sato, Hirohiko; Teramura, Erika; Imai, Jin; Fujisawa, Mia; Tsuruya, Kota; Arase, Yoshitaka; Kagawa, Tatehiro

Low-grade Appendiceal Mucinous Neoplasm with Appendiceal Reduction and Re-expansion Over a Two-year Period

低级别阑尾黏液性肿瘤,阑尾缩小后两年内再次扩张

Deguchi, Ryuzo; Ueda, Takashi; Kaneko, Motoki; Arase, Yoshitaka; Tsuruya, Kota; Kawanishi, Aya; Kodama, Toshiki; Morimachi, Masashi; Ogimi, Takashi; Kagawa, Tatehiro

Construction of a T cell receptor signaling range for spontaneous development of autoimmune disease

构建T细胞受体信号通路范围以促进自身免疫性疾病的自发发展

Atsushi Tanaka # ,Shinji Maeda # ,Takashi Nomura ,Mara Anais Llamas-Covarrubias ,Satoshi Tanaka ,Lin Jin ,Ee Lyn Lim ,Hiromasa Morikawa ,Yohko Kitagawa ,Shuji Akizuki ,Yoshinaga Ito ,Chihiro Fujimori ,Keiji Hirota ,Tosei Murase ,Motomu Hashimoto ,Junichi Higo ,Rose Zamoyska ,Ryuzo Ueda ,Daron M Standley ,Noriko Sakaguchi ,Shimon Sakaguchi

Artesunate and cisplatin synergistically inhibit HNSCC cell growth and promote apoptosis with artesunate‑induced decreases in Rb and phosphorylated Rb levels

青蒿琥酯和顺铂协同抑制 HNSCC 细胞生长并促进细胞凋亡,青蒿琥酯诱导 Rb 和磷酸化 Rb 水平降低

Hiroki Okamoto, Kazuhiro Yoshikawa, Akiko Shimada, Rui Sano, Daisuke Inukai, Shunpei Yamanaka, Susumu Suzuki, Ryuzo Ueda, Hiromi Ueda, Yasushi Fujimoto, Tetsuya Ogawa

Integrated analysis of phase 1a and 1b randomized controlled trials; Treg-targeted cancer immunotherapy with the humanized anti-CCR4 antibody, KW-0761, for advanced solid tumors

对 1a 期和 1b 期随机对照试验进行综合分析;使用人源化抗 CCR4 抗体 KW-0761 进行 Treg 靶向癌症免疫疗法治疗晚期实体瘤

Kaoru Fujikawa,Takuro Saito,Koji Kurose,Takashi Kojima,Takeru Funakoshi,Eiichi Sato,Kazuhiro Kakimi,Shinsuke Iida,Yuichiro Doki,Mikio Oka,Ryuzo Ueda,Hisashi Wada

Trametinib improves Treg selectivity of anti-CCR4 antibody by regulating CCR4 expression in CTLs in oral squamous cell carcinoma

曲美替尼通过调节口腔鳞状细胞癌 CTL 中的 CCR4 表达来改善抗 CCR4 抗体的 Treg 选择性

Shoya Ono, Susumu Suzuki, Yutaro Kondo, Ikuko Okubo, Mitsuo Goto, Tetsuya Ogawa, Hidefumi Kato, Hideaki Ito, Taishi Takahara, Akira Satou, Toyonori Tsuzuki, Kazuhiro Yoshikawa, Toru Nagao, Ryuzo Ueda

Tumor-infiltrating FoxP3+ T cells are associated with poor prognosis in oral squamous cell carcinoma

肿瘤浸润 FoxP3+ T 细胞与口腔鳞状细胞癌预后不良相关

Tomio Hayashi, Kazuhiro Yoshikawa, Susumu Suzuki, Masahiko Gosho, Ryuzo Ueda, Yoshiaki Kazaoka

CCR7 alterations associated with inferior outcome of adult T-cell leukemia/lymphoma under mogamulizumab treatment

CCR7 变异与接受 Mogamulizumab 治疗的成人 T 细胞白血病/淋巴瘤疗效较差相关

Yuma Sakamoto, Takashi Ishida, Ayako Masaki, Takayuki Murase, Eiichi Ohtsuka, Morishige Takeshita, Reiji Muto, Hiromi Iwasaki, Asahi Ito, Shigeru Kusumoto, Nobuaki Nakano, Masahito Tokunaga, Kentaro Yonekura, Yukie Tashiro, Shinsuke Iida, Atae Utsunomiya, Ryuzo Ueda, Hiroshi Inagaki

Depletion of central memory CD8+ T cells might impede the antitumor therapeutic effect of Mogamulizumab

中央记忆CD8+ T细胞的耗竭可能会阻碍莫加莫珠单抗的抗肿瘤治疗效果

Yuka Maeda #,Hisashi Wada #,Daisuke Sugiyama #,Takuro Saito,Takuma Irie,Kota Itahashi,Kodai Minoura,Susumu Suzuki,Takashi Kojima,Kazuhiro Kakimi,Jun Nakajima,Takeru Funakoshi,Shinsuke Iida,Mikio Oka,Teppei Shimamura,Toshihiko Doi,Yuichiro Doki,Eiichi Nakayama,Ryuzo Ueda,Hiroyoshi Nishikawa